Antidiabetics Market Outlook:
Antidiabetics Market size was valued at USD 94.9 billion in 2025 and is expected to reach USD 241.71 billion by 2035, expanding at around 9.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of antidiabetics is evaluated at USD 103.27 billion.
The increasing cases of diabetes, the rising geriatric population, and ongoing advancements in anti-diabetic drugs are positively influencing the overall antidiabetics market growth. According to the World Health Organization (WHO), diabetes is a chronic metabolic disease that affects the eyes, heart, kidneys, and nerves over time. Type 2 diabetes is most common across the world and particularly affects adults. Type 1 diabetes also known as juvenile diabetes or insulin-dependent diabetes is chronic in nature and can be treated through insulin intakes. As per WHO estimations around 422 million people are living with diabetes globally, and about 1.5 million deaths occur yearly due to diabetes.
The rising adoption of a sedentary lifestyle, hike in obesity cases, and poor eating habits are driving the prevalence of diabetes, ultimately augmenting the sales of antidiabetic drugs. According to World Obesity Atlas 2023, more than half of the global population is likely to become obese in the next 12 years if proper treatment and support are not provided. According to the National Center for Biotechnology Information (NCBI), excess amount of body fat is one of the causes of type 2 diabetes.
